-
Framing image registration as a landmark detection problem for label-noise-aware task representation (HitR)
Authors:
Diana Waldmannstetter,
Ivan Ezhov,
Benedikt Wiestler,
Francesco Campi,
Ivan Kukuljan,
Stefan Ehrlich,
Shankeeth Vinayahalingam,
Bhakti Baheti,
Satrajit Chakrabarty,
Ujjwal Baid,
Spyridon Bakas,
Julian Schwarting,
Marie Metz,
Jan S. Kirschke,
Daniel Rueckert,
Rolf A. Heckemann,
Marie Piraud,
Bjoern H. Menze,
Florian Kofler
Abstract:
Accurate image registration is pivotal in biomedical image analysis, where selecting suitable registration algorithms demands careful consideration. While numerous algorithms are available, the evaluation metrics to assess their performance have remained relatively static. This study addresses this challenge by introducing a novel evaluation metric termed Landmark Hit Rate (HitR), which focuses on…
▽ More
Accurate image registration is pivotal in biomedical image analysis, where selecting suitable registration algorithms demands careful consideration. While numerous algorithms are available, the evaluation metrics to assess their performance have remained relatively static. This study addresses this challenge by introducing a novel evaluation metric termed Landmark Hit Rate (HitR), which focuses on the clinical relevance of image registration accuracy. Unlike traditional metrics such as Target Registration Error, which emphasize subresolution differences, HitR considers whether registration algorithms successfully position landmarks within defined confidence zones. This paradigm shift acknowledges the inherent annotation noise in medical images, allowing for more meaningful assessments. To equip HitR with label-noise-awareness, we propose defining these confidence zones based on an Inter-rater Variance analysis. Consequently, hit rate curves are computed for varying landmark zone sizes, enabling performance measurement for a task-specific level of accuracy. Our approach offers a more realistic and meaningful assessment of image registration algorithms, reflecting their suitability for clinical and biomedical applications.
△ Less
Submitted 1 July, 2024; v1 submitted 31 July, 2023;
originally announced August 2023.
-
Primitive Simultaneous Optimization of Similarity Metrics for Image Registration
Authors:
Diana Waldmannstetter,
Benedikt Wiestler,
Julian Schwarting,
Ivan Ezhov,
Marie Metz,
Spyridon Bakas,
Bhakti Baheti,
Satrajit Chakrabarty,
Daniel Rueckert,
Jan S. Kirschke,
Rolf A. Heckemann,
Marie Piraud,
Bjoern H. Menze,
Florian Kofler
Abstract:
Even though simultaneous optimization of similarity metrics is a standard procedure in the field of semantic segmentation, surprisingly, this is much less established for image registration. To help closing this gap in the literature, we investigate in a complex multi-modal 3D setting whether simultaneous optimization of registration metrics, here implemented by means of primitive summation, can b…
▽ More
Even though simultaneous optimization of similarity metrics is a standard procedure in the field of semantic segmentation, surprisingly, this is much less established for image registration. To help closing this gap in the literature, we investigate in a complex multi-modal 3D setting whether simultaneous optimization of registration metrics, here implemented by means of primitive summation, can benefit image registration. We evaluate two challenging datasets containing collections of pre- to post-operative and pre- to intra-operative MR images of glioma. Employing the proposed optimization, we demonstrate improved registration accuracy in terms of TRE on expert neuroradiologists' landmark annotations.
△ Less
Submitted 12 October, 2023; v1 submitted 4 April, 2023;
originally announced April 2023.
-
Federated Learning Enables Big Data for Rare Cancer Boundary Detection
Authors:
Sarthak Pati,
Ujjwal Baid,
Brandon Edwards,
Micah Sheller,
Shih-Han Wang,
G Anthony Reina,
Patrick Foley,
Alexey Gruzdev,
Deepthi Karkada,
Christos Davatzikos,
Chiharu Sako,
Satyam Ghodasara,
Michel Bilello,
Suyash Mohan,
Philipp Vollmuth,
Gianluca Brugnara,
Chandrakanth J Preetha,
Felix Sahm,
Klaus Maier-Hein,
Maximilian Zenk,
Martin Bendszus,
Wolfgang Wick,
Evan Calabrese,
Jeffrey Rudie,
Javier Villanueva-Meyer
, et al. (254 additional authors not shown)
Abstract:
Although machine learning (ML) has shown promise in numerous domains, there are concerns about generalizability to out-of-sample data. This is currently addressed by centrally sharing ample, and importantly diverse, data from multiple sites. However, such centralization is challenging to scale (or even not feasible) due to various limitations. Federated ML (FL) provides an alternative to train acc…
▽ More
Although machine learning (ML) has shown promise in numerous domains, there are concerns about generalizability to out-of-sample data. This is currently addressed by centrally sharing ample, and importantly diverse, data from multiple sites. However, such centralization is challenging to scale (or even not feasible) due to various limitations. Federated ML (FL) provides an alternative to train accurate and generalizable ML models, by only sharing numerical model updates. Here we present findings from the largest FL study to-date, involving data from 71 healthcare institutions across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, utilizing the largest dataset of such patients ever used in the literature (25,256 MRI scans from 6,314 patients). We demonstrate a 33% improvement over a publicly trained model to delineate the surgically targetable tumor, and 23% improvement over the tumor's entire extent. We anticipate our study to: 1) enable more studies in healthcare informed by large and diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further quantitative analyses for glioblastoma via performance optimization of our consensus model for eventual public release, and 3) demonstrate the effectiveness of FL at such scale and task complexity as a paradigm shift for multi-site collaborations, alleviating the need for data sharing.
△ Less
Submitted 25 April, 2022; v1 submitted 22 April, 2022;
originally announced April 2022.
-
Learn-Morph-Infer: a new way of solving the inverse problem for brain tumor modeling
Authors:
Ivan Ezhov,
Kevin Scibilia,
Katharina Franitza,
Felix Steinbauer,
Suprosanna Shit,
Lucas Zimmer,
Jana Lipkova,
Florian Kofler,
Johannes Paetzold,
Luca Canalini,
Diana Waldmannstetter,
Martin Menten,
Marie Metz,
Benedikt Wiestler,
Bjoern Menze
Abstract:
Current treatment planning of patients diagnosed with a brain tumor, such as glioma, could significantly benefit by accessing the spatial distribution of tumor cell concentration. Existing diagnostic modalities, e.g. magnetic resonance imaging (MRI), contrast sufficiently well areas of high cell density. In gliomas, however, they do not portray areas of low cell concentration, which can often serv…
▽ More
Current treatment planning of patients diagnosed with a brain tumor, such as glioma, could significantly benefit by accessing the spatial distribution of tumor cell concentration. Existing diagnostic modalities, e.g. magnetic resonance imaging (MRI), contrast sufficiently well areas of high cell density. In gliomas, however, they do not portray areas of low cell concentration, which can often serve as a source for the secondary appearance of the tumor after treatment. To estimate tumor cell densities beyond the visible boundaries of the lesion, numerical simulations of tumor growth could complement imaging information by providing estimates of full spatial distributions of tumor cells. Over recent years a corpus of literature on medical image-based tumor modeling was published. It includes different mathematical formalisms describing the forward tumor growth model. Alongside, various parametric inference schemes were developed to perform an efficient tumor model personalization, i.e. solving the inverse problem. However, the unifying drawback of all existing approaches is the time complexity of the model personalization which prohibits a potential integration of the modeling into clinical settings. In this work, we introduce a deep learning based methodology for inferring the patient-specific spatial distribution of brain tumors from T1Gd and FLAIR MRI medical scans. Coined as Learn-Morph-Infer the method achieves real-time performance in the order of minutes on widely available hardware and the compute time is stable across tumor models of different complexity, such as reaction-diffusion and reaction-advection-diffusion models. We believe the proposed inverse solution approach not only bridges the way for clinical translation of brain tumor personalization but can also be adopted to other scientific and engineering domains.
△ Less
Submitted 25 October, 2022; v1 submitted 7 November, 2021;
originally announced November 2021.
-
Geometry-aware neural solver for fast Bayesian calibration of brain tumor models
Authors:
Ivan Ezhov,
Tudor Mot,
Suprosanna Shit,
Jana Lipkova,
Johannes C. Paetzold,
Florian Kofler,
Fernando Navarro,
Chantal Pellegrini,
Marcel Kollovieh,
Marie Metz,
Benedikt Wiestler,
Bjoern Menze
Abstract:
Modeling of brain tumor dynamics has the potential to advance therapeutic planning. Current modeling approaches resort to numerical solvers that simulate the tumor progression according to a given differential equation. Using highly-efficient numerical solvers, a single forward simulation takes up to a few minutes of compute. At the same time, clinical applications of tumor modeling often imply so…
▽ More
Modeling of brain tumor dynamics has the potential to advance therapeutic planning. Current modeling approaches resort to numerical solvers that simulate the tumor progression according to a given differential equation. Using highly-efficient numerical solvers, a single forward simulation takes up to a few minutes of compute. At the same time, clinical applications of tumor modeling often imply solving an inverse problem, requiring up to tens of thousands forward model evaluations when used for a Bayesian model personalization via sampling. This results in a total inference time prohibitively expensive for clinical translation. While recent data-driven approaches become capable of emulating physics simulation, they tend to fail in generalizing over the variability of the boundary conditions imposed by the patient-specific anatomy. In this paper, we propose a learnable surrogate for simulating tumor growth which maps the biophysical model parameters directly to simulation outputs, i.e. the local tumor cell densities, whilst respecting patient geometry. We test the neural solver on Bayesian tumor model personalization for a cohort of glioma patients. Bayesian inference using the proposed surrogate yields estimates analogous to those obtained by solving the forward model with a regular numerical solver. The near-real-time computation cost renders the proposed method suitable for clinical settings. The code is available at https://github.com/IvanEz/tumor-surrogate.
△ Less
Submitted 14 April, 2021; v1 submitted 9 September, 2020;
originally announced September 2020.
